Merck & Co. (MRK)
(Delayed Data from NYSE)
$93.13 USD
+1.13 (1.23%)
Updated Jun 24, 2022 04:06 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 37% (157 out of 250)Zacks Sector Rank
Top 44% (7 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 2.10 | 9.99 |
Current Quarter Estimate | 1.68 | 37.64 | 54.90 |
Year Ago Quarter Estimate | 1.31 | 11.39 | 45.95 |
Next Quarter Estimate | 1.87 | 34.85 | 56.00 |
Next Year Estimate | 7.19 | 178.47 | 240.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 21.43 | 6.20 | 8.26 |
Next Year | -1.64 | 7.80 | 6.48 |
Last 5 Years | 9.70 | 11.30 | 13.40 |
Next 5 Years | 10.10 | 9.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 13.30 | 15.53 |
Price/Book (MRQ) | 5.75 | 4.33 |
Price/Cash Flow (MRFY) | 12.73 | 10.20 |
Dividend Yield | 2.96% | 2.61% |
Net Profit Margin (TTM) | 26.27% | 21.45% |
Return on Equity (TTM) | 47.86% | 37.44% |
Debt to Equity (MRQ) | 0.75 | 43.58 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.